{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:06:31Z","timestamp":1790355991309,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009768","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000}}],"reference-count":123,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009768.pub2","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T11:23:19Z","timestamp":1548847399000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition"],"prefix":"10.1002","volume":"2019","author":[{"given":"Sheila A","family":"Fisher","sequence":"first","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; Level 2, John Radcliffe Hospital Headington Oxford Oxon UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Cutler","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Histocompatibility & Immunogenetics Research Group; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; Level 2, John Radcliffe Hospital Headington Oxford Oxon UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J","family":"Brunskill","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; Level 2, John Radcliffe Hospital Headington Oxford Oxon UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Stanworth","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust and University of Oxford; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital, Headley Way Headington Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Navarrete","sequence":"additional","affiliation":[{"name":"University College London; Division of Infection and Immunity; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Girdlestone","sequence":"additional","affiliation":[{"name":"University College London; Division of Infection and Immunity; London UK"},{"name":"NHS Blood and Transplant; Stem Cells and Immunotherapies; Headley Way Oxford UK OX3 9BQ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"10.1002\/14651858.CD009768.pub2-BIB0001|cit1","unstructured":"ChiCTR-IOR-15006330 Disease after HLA-haploidentical stem cell transplantation - A prospective, randomized, parallel-group study http:\/\/www.chictr.org.cn\/showproj.aspx?proj=10892"},{"issue":"24","key":"10.1002\/14651858.CD009768.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1200\/JCO.2015.65.3642","article-title":"Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation","volume":"34","author":"Gao","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009768.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1016\/j.bbmt.2009.12.183","article-title":"Co-transplantation of HLA-matched related donors culture-expanded mesenchymal stromal cells and hematopoietic stem cells in thalassemia major patients","volume":"16","author":"Ghavamzadeh","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009768.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.bbmt.2009.12.024","article-title":"Hematopoietic stem cell transplantation for major thalassemia: Nineteen years experience in Iran","volume":"16","author":"Ghavamzadeh","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0005|cit5","unstructured":"EUCTR2008-004014-27-ES Randomized and controlled multicentre phase I\/II clinical trial for the safety assessment and feasibility of therapy with two different doses of mesenchymal stem cells from adipose tissue in patients with extensive graft-versus-host disease https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2008-004014-27"},{"issue":"5 (Suppl.)","key":"10.1002\/14651858.CD009768.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jcyt.2017.02.015","article-title":"A multicenter randomized clinical trial evaluating the safety and feasibility of the treatment of GVHD with allogenic mesenchymal stem cells (MSC) from adipose tissue","volume":"9","author":"Jurado","year":"2017","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1002\/14651858.CD009768.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcyt.2017.05.002","article-title":"Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I\/II study","volume":"19","author":"Jurado","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0008|cit8","unstructured":"NCT01222039 Multicenter clinical trial for the evaluation of mesenchymal stem cells from adipose tissue in patients with chronic graft versus host disease. (CMM\/EICH\/2008) clinicaltrials.gov\/show\/NCT01222039"},{"issue":"Suppl 1S","key":"10.1002\/14651858.CD009768.pub2-BIB0009|cit9","first-page":"S184","article-title":"Multipotent mesenchymal stromal cells as graft-versus-host disease prophylaxis: A prospective randomised clinical trial","volume":"50","author":"Kuzmina","year":"2015","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"Article ID 9682","DOI":"10.1155\/2012\/968213","article-title":"Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease - A phase II study","volume":"2012","author":"Kuzmina","year":"2012","journal-title":"Stem Cells International"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0011|cit11","unstructured":"NCT01941394 Mesenchymal stem cells infusion for aGVHD prophylaxis transplantation clinicaltrials.gov\/show\/NCT01941394"},{"issue":"S1","key":"10.1002\/14651858.CD009768.pub2-BIB0012|cit12","first-page":"281","article-title":"Factors determining the effectiveness of acute graft versus host disease prophylaxis after allogeneic bone marrow transplantation with multipotent mesenchymal stromal cells","volume":"100","author":"Petinati","year":"2015","journal-title":"Haematologica"},{"issue":"21","key":"10.1002\/14651858.CD009768.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood.V116.21.1256.1256","article-title":"Multipotent mesenchymal stromal cells as graft-versus-host disease prophylaxis: A prosective randomised clinical trial","volume":"116","author":"Petinati","year":"2010","journal-title":"Blood"},{"issue":"21","key":"10.1002\/14651858.CD009768.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V124.21.2484.2484","article-title":"Characteristics of mesenchymal multipotent stromal cells determine their effectiveness for acute graft versus host disease prophylaxis after allogeneic bone marrow transplantation","volume":"124","author":"Shipounova","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD009768.pub2-BIB0015|cit15","first-page":"1363","article-title":"Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation","volume":"79","author":"Shipounova","year":"2014","journal-title":"Biochemistry"},{"issue":"10","key":"10.1002\/14651858.CD009768.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1089\/scd.2010.0447","article-title":"Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: A randomized, controlled clinical study","volume":"20","author":"Liu","year":"2011","journal-title":"Stem Cells and Development"},{"issue":"11","key":"10.1002\/14651858.CD009768.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1182\/blood.V112.11.3284.3284","article-title":"Cotransplantation of mesenchymal stem cells prompted platelets recovery in HLA-haploidentical\/mismatched blood and marrow transplantation: A randomized phase II study","volume":"112","author":"Liu","year":"2008","journal-title":"Blood"},{"issue":"S2","key":"10.1002\/14651858.CD009768.pub2-BIB0018|cit18","first-page":"223","article-title":"A randomized controlled clinical study: coinfusing of mesenchymal stem cells in haploidentical hematopoietic stem-cell transplantation can facilitate platelet recovery but fail to prevent GVHD","volume":"94","author":"Liu","year":"2009","journal-title":"Haematologica"},{"issue":"Suppl 1S","key":"10.1002\/14651858.CD009768.pub2-BIB0019|cit19","first-page":"S118","article-title":"Influence of mesenchymal stem cells co-transplantation on post-transplant period after allogeneic hematopoietic cell transplantation in children with acute leukemia","volume":"51","author":"Mareika","year":"2016","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD009768.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia"},{"issue":"9","key":"10.1002\/14651858.CD009768.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood.V108.11.3231.3231","article-title":"Phase II trial of ProchymalTM (ex-vivo cultured adult human mesenchymal stem cells) and corticosteroids as primary treatment for acute graft-vs-host disease (aGVHD)","volume":"108","author":"Kebriaei","year":"2006","journal-title":"Blood"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD009768.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbmt.2006.12.311","article-title":"Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (AGVHD)","volume":"13","author":"Kebriaei","year":"2007","journal-title":"Biology of Bone Marrow Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD009768.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","article-title":"Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease","volume":"15","author":"Kebriaei","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0024|cit24","unstructured":"NCT00136903 Safety and efficacy study of adult human mesenchymal stem cells to treat acute GVHD https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00136903"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0025|cit25","unstructured":"NCT00562497 Efficacy and safety of Prochymal\u2122 infusion in combination with corticosteroids for the treatment of newly diagnosed acute GVHD https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00562497"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0026|cit26","unstructured":"Osiris Therapeutics Inc Press Release 8 September 2009: Osiris Therapeutics announces preliminary results for Prochymal phase II GvHD trials [http:\/\/investor.osiris.com\/releasedetail.cfm?releaseID=407404]"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0027|cit27","unstructured":"Australian Public Assessment Report for Remestemcel-L, ex vivo adult human mesenchymal stem cells, 2015 Therapeutic Goods Administration, used by permission of the Australian Government [https:\/\/www.tga.gov.au\/node\/537352]"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0029|cit28","unstructured":"Extract from the clinical evaluation report for Remestemcel-L, ex vivo adult human mesenchymal stem cells, 2015 Therapeutic Goods Administration, used by permission of the Australian Government [https:\/\/www.tga.gov.au\/node\/537352]"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0028|cit29","unstructured":"EUCTR2006-004420-37-IT A phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Prochymal (ex-vivo cultured adult human mesenchymal stem cells) infusion for the treatment of patients who have failed to respond to steroid treatment for acute GVHD https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2006-004420-37\/GB"},{"issue":"Suppl 2S","key":"10.1002\/14651858.CD009768.pub2-BIB0030|cit30","first-page":"S17","article-title":"Prochymal\u00ae improves response rates in patients with steroid-refractory acute graft-versus-host disease involving the liver and gut: Results of a randomized, placebo-controlled, multicentre phase III trial in GvHD","volume":"45","author":"Martin","year":"2010","journal-title":"Bone Marrow Transplantation"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009768.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bbmt.2009.12.057","article-title":"Prochymal improves response rates in patients with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: Results of a randomized, placebo-controlled, multicenter phase III trial in GVHD","volume":"16","author":"Martin","year":"2010","journal-title":"Biology of Blood and Marrow Transplatation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0032|cit32","unstructured":"NCT00366145 Efficacy and safety of adult human mesenchymal stem cells to treat steroid refractory acute graft versus host disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00366145"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0033|cit33","unstructured":"Osiris Therapeutics Inc Press Release 8 September 2009: Osiris Therapeutics announces preliminary results for Prochymal phase II GvHD trials [http:\/\/investor.osiris.com\/releasedetail.cfm?releaseID=407404]"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009768.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S298","DOI":"10.1016\/j.bbmt.2009.12.426","article-title":"Treatment of steroid-refractory acute GVHD with mesenchymal stem cells improves outcomes in pediatric patients; results of the pediatric subset in a phase III randomized, placebo-controlled study","volume":"16","author":"Szabolcs","year":"2010","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"Suppl 2S","key":"10.1002\/14651858.CD009768.pub2-BIB0035|cit35","first-page":"S18","article-title":"Treatment of steroid-refractory acute GvHD with mesenchymal stem cells improves outcomes in paediatric patients. Results of the paediatric subset in a phase III randomized, placebo-controlled study","volume":"45","author":"Szabolcs","year":"2010","journal-title":"Bone Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD009768.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3727\/096368912X663533","article-title":"Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation","volume":"22","author":"Wu","year":"2013","journal-title":"Cell Transplantation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0037|cit37","unstructured":"NCT01526850 Efficacy and safety study of allogenic mesenchymal stem cells for patients with chronic graft versus host disease (MSCsTcGVHD) clinicaltrials.gov\/show\/NCT01526850"},{"issue":"Suppl 1S","key":"10.1002\/14651858.CD009768.pub2-BIB0038|cit38","first-page":"S148","article-title":"MSC cavity injection boosts Th1 subset and has good response in extensive cGVHD patients: A prospective multicentre randomized controlled trial","volume":"50","author":"Zheng","year":"2015","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD009768.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cellimm.2015.07.001","article-title":"Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas","volume":"297","author":"Batorov","year":"2015","journal-title":"Cell Immunology"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD009768.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1016\/j.bbmt.2011.12.181","article-title":"Treatment of steroid resistant grade II to IV acute GVHD by infusion of mesenchymal stroma cells expanded with human plasma and platelet lysate - A phase I\/II study","volume":"18","author":"Boome","year":"2012","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0041|cit41","unstructured":"EUCTR2007-003341-32-NL Treatment of steroid resistant grade II to IV acute GVHD by infusion of mesenchymal stem cells expanded with human plasma and platelet lysate ; a phase I\/II study - MSC for resistant GVHD https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2007-003341-32\/NL"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0042|cit42","unstructured":"EUCTR2005-003674-14-ES A Phase I\/II clinical trial for the treatment of refractory graft-versus-host disease through the infusion of allogeneic mesenchymal cells expanded in vitro https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2005-003674-14\/ES"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0043|cit43","unstructured":"EUCTR2008-007869-23-IT Mesenchymal stromal cells (MSC) for the treatment of severe (grade II-IV) steroid-resistant graft versus host disease (GVHD): a phase I trial - MSC-GvHD https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2008-007869-23\/IT"},{"issue":"3","key":"10.1002\/14651858.CD009768.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/14653240902807018","article-title":"Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults","volume":"11","author":"Gonzalo-Daganzo","year":"2009","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1002\/14651858.CD009768.pub2-BIB0045|cit45","first-page":"1084","article-title":"Effect of umbilical cord MSC infusion on the pulmonary infection in haploidentical hematopoietic stem cell transplantation [Chinese]","volume":"22","author":"Han","year":"2014","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1002\/14651858.CD009768.pub2-BIB0046|cit46","first-page":"155","article-title":"Transfusion of mesenchymal stem cells combined with haploidentical HSCT improves hematopoietic microenvironment [Chinese]","volume":"18","author":"Hou","year":"2010","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"7","key":"10.1002\/14651858.CD009768.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2298\/VSP130410050I","article-title":"Manufactoruing and use of human placenta-derived mesenchymal stromal cells for phase I clinical trials: establishment and evaluation of a protocol","volume":"71","author":"Ilic","year":"2014","journal-title":"Vojnosanitetski Pregled"},{"issue":"3","key":"10.1002\/14651858.CD009768.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2013.11.033","article-title":"Treatment of graft versus host disease with mesenchymal stromal cells: A phase I study on 40 adult and pediatric patients","volume":"20","author":"Introna","year":"2014","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0049|cit49","unstructured":"JPRN-C000000423 Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000000507"},{"issue":"9 Suppl 1","key":"10.1002\/14651858.CD009768.pub2-BIB0050|cit50","first-page":"S42","article-title":"Cotransplantation of mesenchymal stromal cells and hematopoietic stem cells in patients with hematologic malignancies","volume":"37","author":"Kozlov","year":"2009","journal-title":"Experimental Hematology"},{"issue":"5","key":"10.1002\/14651858.CD009768.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD009768.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1182\/blood.V110.11.4974.4974","article-title":"Treatment of intractable graft-versus-host disease with bone marrow derived mesenchymal stem cells - a pilot clinical trial","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD009768.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/bmt.2013.7","article-title":"Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation","volume":"48","author":"Lee","year":"2013","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0054|cit54","unstructured":"NCT00823316 Safety and efficacy study of umbilical cord blood-derived mesenchymal stem cells to promote engraftment of unrelated hematopoietic stem cell transplantation clinicaltrials.gov\/show\/NCT00823316"},{"issue":"6","key":"10.1002\/14651858.CD009768.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bmt.2008.348","article-title":"Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial","volume":"43","author":"Macmillan","year":"2009","journal-title":"Bone Marrow Transplantation"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD009768.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1016\/j.bbmt.2010.12.214","article-title":"Stromal stem cell therapy for prophylaxis of acute GVHD: Preliminary results from a phase I trial","volume":"17","author":"Maziarz","year":"2011","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD009768.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1016\/j.bbmt.2011.12.180","article-title":"Prophylaxis of acute GVHD using MultiStem\u00ae stromal cell therapy: Preliminary results after administration of single or multiple doses in a phase I trial","volume":"18","author":"Maziarz","year":"2012","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD009768.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbmt.2014.12.025","article-title":"Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative hematopoietic cell transplantation: A phase I trial","volume":"21","author":"Maziarz","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"21","key":"10.1002\/14651858.CD009768.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V118.21.1987.1987","article-title":"Prophylaxis of acute GVHD using stromal cell therapy: preliminary results after administration of single or multiple doses of MultiStem\u00ae in a phase I trial","volume":"118","author":"Maziarz","year":"2011","journal-title":"Blood"},{"issue":"S1","key":"10.1002\/14651858.CD009768.pub2-BIB0060|cit60","first-page":"338","article-title":"A novel mesenchymal stem cell therapy in steroid refractory graft-versus-host disease","volume":"113","author":"Molnar","year":"2018","journal-title":"Vox Sanguinis"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0061|cit61","unstructured":"NCT00081055 OTI-010 for graft-versus-host disease prophylaxis in treating patients who are undergoing donor peripheral stem cell transplantation for hematologic malignancies clinicaltrials.gov\/show\/NCT00081055"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0062|cit62","unstructured":"NCT01129739 Safety and efficacy study of umbilical cord\/placenta-derived mesenchymal stem cells to treat myelodysplastic syndromes clinicaltrials.gov\/show\/NCT01129739"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0063|cit63","unstructured":"NCT01182662 Safety and efficacy study of umbilical cord\/placenta-derived mesenchymal stem cells to treat severe aplastic anemia clinicaltrials.gov\/show\/NCT01182662"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0064|cit64","unstructured":"NCT01854567 P3 study of umbilical cord blood cells expanded with MPCs for transplantation in patients with hematologic malignancies clinicaltrials.gov\/show\/NCT01854567"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0065|cit65","unstructured":"NCT02240992 MSCs with or without peripheral blood stem cell for treatment of poor graft function and delayed platelet engraftment clinicaltrials.gov\/show\/NCT02240992"},{"issue":"21","key":"10.1002\/14651858.CD009768.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood.V118.21.3042.3042","article-title":"Mesenchymal stem cells as a treatment for steroid-resistant acute graft versus host disease (aGVHD); a multicenter phase I\/II study","volume":"118","author":"Ozawa","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD009768.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3324\/haematol.2010.038356","article-title":"Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I\/II clinical trial","volume":"96","author":"Perez-Simon","year":"2011","journal-title":"Haematologica"},{"issue":"22","key":"10.1002\/14651858.CD009768.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood.V114.22.2249.2249","article-title":"Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells","volume":"114","author":"Resnick","year":"2009","journal-title":"Blood"},{"issue":"Suppl 1S","key":"10.1002\/14651858.CD009768.pub2-BIB0069|cit69","first-page":"S30","article-title":"Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem-cell transplantation in patients with severe aplastic anemia: Multicenter phase II trial results","volume":"51","author":"Xiao","year":"2016","journal-title":"Bone Marrow Transplantation"},{"issue":"S1","key":"10.1002\/14651858.CD009768.pub2-BIB0070|cit70","first-page":"150","article-title":"Comparison of mesenchymal stem cells and mesenchymal stem cells combined with cord blood for treatment of engraft failure following autologous hematopoietic stem cell transplantation","volume":"98","author":"Liu","year":"2013","journal-title":"Haematologica"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0071|cit71","unstructured":"NCT01763099 Mesenchymal stem cells combined with cord blood for treatment of graft failure clinicaltrials.gov\/show\/NCT01763099"},{"issue":"2","key":"10.1002\/14651858.CD009768.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbmt.2013.11.002","article-title":"Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: A pilot prospective, open-label, randomized trial","volume":"20","author":"Xiong","year":"2014","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"21","key":"10.1002\/14651858.CD009768.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood.V122.21.3693.3693","article-title":"Mesenchymal stem cells vs mesenchymal stem cells combined with cord blood for treating engraftment failure following autologous hematopoietic stem cell transplantation: A pilot prospective study","volume":"122","author":"Xiong","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD009768.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbmt.2014.09.030","article-title":"Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation","volume":"21","author":"Zhao","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD009768.pub2-BIB0075|cit75","first-page":"293","article-title":"Outcomes of co-transplantation of mesenchymal stem cells and hematopoietic stem cells compared to hematopoietic stem cell transplantation alone in -thalassemia patients","volume":"52","author":"Ghavamzadeh","year":"2017","journal-title":"Bone Marrow Transplantation"},{"issue":"29","key":"10.1002\/14651858.CD009768.pub2-BIB0076|cit76","first-page":"4679","article-title":"Effect of human umbilical cord mesenchymal stem cells on immune reconstruction of acute lymphoblastic leukemia children undergoing allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Xiang","year":"2017","journal-title":"Chinese Journal of Tissue Engineering Research"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0077|cit77","unstructured":"ACTRN12608000129381 Cotransplantation of mesenchymal stem cells with nonmyeloablative haploidentical peripheral blood stem cells without T cells deleted for high-risk acute leukemia: to reduce the severity of graft versus host disease and relapse http:\/\/www.anzctr.org.au\/ACTRN12608000129381.aspx"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0078|cit78","unstructured":"ChiCTR-IIR-16007806 Clincal study of umbilical cord-derived mesenchymal stem cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem cell transpantation--multicenter, randomized parallel controlled, double-blind trial http:\/\/www.chictr.org.cn\/showproj.aspx?proj=13052"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0079|cit79","unstructured":"ChiCTR-INR-16008399 Cotransplantation of haploidentical peripheral blood stem cells and mesenchymal stem cells for acute leukemia: a randomized, controlled clinical study http:\/\/www.chictr.org.cn\/showproj.aspx?proj=14141"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0080|cit80","unstructured":"EUCTR2008-005594-35-BE Randomized double-blind study of mesenchymal stem cells (MSC) in patients undergoing matched unrelated allogeneic bone marrow or peripheral blood stem cell transplantation- A European multicentre study https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2008-005594-35\/BE"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0081|cit81","unstructured":"EUCTR2009-014980-38-BE Co-transplantation of mesenchymal stem cells and HLA-mismatched allogeneic hematopoietic cells after reduced-intensity conditioning: a phase II randomized double-blind study https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2009-014980-38\/BE"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0082|cit82","unstructured":"EUCTR2011-003237-33-NL Treatment of severe acute GVHD after allogeneic hematopoietic stem cell transplantation with steroids versus MSC and steroids. A prospective double-blind placebo-controlled randomized phase III trial https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2011-003237-33\/NL"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0083|cit83","unstructured":"EUCTR2012-004915-30-NL Treatment of severe steroid-refractory acute GvHD with mesenchymal stromal cells. https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2012-004915-30\/NL"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0084|cit84","unstructured":"ChiCTR-TRC-09000536 A phase II, randomized study to evaluate the safety and efficacy of ex-vivo cultured allogenic mesenchymal stem cells for the treatment of extensive chronic graft versus host disease http:\/\/www.chictr.org.cn\/showproj.aspx?proj=8999"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0085|cit85","unstructured":"NCT00972660 Safety and efficacy study of allogenic mesenchymal stem cells to treat extensive chronic graft versus host disease clinicaltrials.gov\/show\/NCT00972660"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0086|cit86","unstructured":"NCT01045382 MSC and HSC coinfusion in mismatched minitransplants clinicaltrials.gov\/show\/NCT01045382"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0087|cit87","unstructured":"NCT01589549 Mesenchymal stromal cells for acute graft versus host disease clinicaltrials.gov\/show\/NCT01589549"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0088|cit88","unstructured":"NCT02241018 MSCs combined with CD25 monoclonal antibody and calcineurin inhibitors for treatment of steroid-resistant aGVHD clinicaltrials.gov\/show\/NCT02241018"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0089|cit89","unstructured":"NCT02291770 Treatment of chronic graft-versus-host disease with mesenchymal stromal cells (MSC-cGvHD) clinicaltrials.gov\/show\/NCT02291770"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0090|cit90","unstructured":"NCT02770430 Mesenchymal stem cells as first treatment line for resistant acute graft versus host disease clinicaltrials.gov\/show\/NCT02770430"},{"issue":"2","key":"10.1002\/14651858.CD009768.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.imlet.2015.06.006","article-title":"Clinical grade expansion of MSCs","volume":"168","author":"Capelli","year":"2015","journal-title":"Immunology Letters"},{"issue":"5","key":"10.1002\/14651858.CD009768.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"Journal of Cell Biochemistry"},{"issue":"8","key":"10.1002\/14651858.CD009768.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"e0136991","DOI":"10.1371\/journal.pone.0136991","article-title":"Efficacy of mesenchymal stem cell therapy for steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis","volume":"10","author":"Chen","year":"2015","journal-title":"PLOS One"},{"issue":"1","key":"10.1002\/14651858.CD009768.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.beha.2011.01.002","article-title":"Mesenchymal stem cells and autoimmune diseases","volume":"24","author":"Dazzi","year":"2011","journal-title":"Best Practice and Research: Clinical Haematology"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0095|cit95","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011 2011. Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD009768.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1002\/14651858.CD009768.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2010.09.009","article-title":"Mesenchymal stromal cells: facilitators of successful transplantation?","volume":"7","author":"English","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1196\/annals.1392.025","article-title":"Modulation of immune responses by mesenchymal stem cells","volume":"1106","author":"Fibbe","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"10.1002\/14651858.CD009768.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2014-08-551994","article-title":"How we treat chronic graft-versus-host disease","volume":"125","author":"Flowers","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD009768.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","article-title":"In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis","volume":"38","author":"Gholamrezanezhad","year":"2011","journal-title":"Nuclear Medicine and Biology"},{"issue":"22","key":"10.1002\/14651858.CD009768.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD009768.pub2-BIB0102|cit102","first-page":"526","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"Journal of the American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD009768.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3026(15)00224-0","article-title":"Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis","volume":"3","author":"Hashmi","year":"2016","journal-title":"Lancet Haematology"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0104|cit104","unstructured":"Higgins JP Deeks JJ Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0105|cit105","unstructured":"Higgins JP Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009768.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychological Methods"},{"issue":"7626","key":"10.1002\/14651858.CD009768.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD009768.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcyt.2015.11.010","article-title":"Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis","volume":"18","author":"Kallekleiv","year":"2016","journal-title":"Cytotherapy"},{"issue":"10","key":"10.1002\/14651858.CD009768.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLOs One"},{"issue":"9624","key":"10.1002\/14651858.CD009768.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0111|cit111","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, (editors). In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13287-015-0271-2","article-title":"Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells","volume":"7","author":"Leibacher","year":"2016","journal-title":"Stem Cell Research and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD009768.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V76.8.1464.1464","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment","volume":"76","author":"Martin","year":"1990","journal-title":"Blood"},{"issue":"24","key":"10.1002\/14651858.CD009768.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009768.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","article-title":"Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications","volume":"23","author":"Rani","year":"2015","journal-title":"Molecular Therapy"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0116|cit116","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"1","key":"10.1002\/14651858.CD009768.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beha.2011.01.003","article-title":"Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages","volume":"24","author":"Ringden","year":"2011","journal-title":"Best Practice and Research: Clinical Haematology"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0118|cit118","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JP, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD009768.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"7","key":"10.1002\/14651858.CD009768.pub2-BIB0121|cit121","first-page":"2288","article-title":"Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial\u00a0from the Italian Group for Bone Marrow Transplantation","volume":"92","author":"Lint","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009768.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00277-018-3384-8","article-title":"Efficacy and safety of mesenchymal stromal cells for the prophylaxis of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials","volume":"97","author":"Wang","year":"2018","journal-title":"Annals of Hematology"},{"issue":"5","key":"10.1002\/14651858.CD009768.pub2-BIB0123|cit123","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009768","article-title":"Mesenchymal stromal cells (MSC) for treating immune-mediated inflammation post-transplantation and in autoimmunity","author":"Cutler","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009768.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T04:04:57Z","timestamp":1687233897000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009768.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":123,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009768.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}